M. Tonato, MD | Authors

Quality-of-Life Improvement in Patients Receiving Paclitaxel/Platinum Regimens

September 01, 1999

The combination regimen of paclitaxel (Taxol) and cisplatin (Platinol) for non–small-cell lung cancer has shown improved response rates in some phase II trials, and because of its safety profile, it could offer patients with this